Haemonetics (HAE) Return on Invested Capital Growth (1y) (2011 - 2026)

Haemonetics (HAE) Return on Invested Capital Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC Growth (1y) (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -1.00
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 0.00
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 0.00
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 0.00
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 0.00
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 0.00
10 Haemonetics 3.78 Bn 3.54 Bn 198.21 Mn -1.00

Historic Data

Download Data
DateValue
Mar 28, 2026 -1.00
Dec 27, 2025 -5.00
Sep 27, 2025 -3.00
Jun 28, 2025 -2.00
Mar 29, 2025 -1.00
Dec 28, 2024 2.00
Sep 28, 2024 1.00
Jun 29, 2024 1.00
Mar 30, 2024 2.00
Dec 30, 2023 2.00
Sep 30, 2023 2.00
Jul 1, 2023 1.00
Apr 1, 2023 1.00
Dec 31, 2022 0.00
Oct 1, 2022 0.00
Jul 2, 2022 0.00
Apr 2, 2022 0.00
Jan 1, 2022 0.00
Oct 2, 2021 0.00
Jul 3, 2021 0.00